Range of tumor cells positive for NY-ESO-1 (2+/3+ per IHC) d 30-100 70-100 Range of H score for NY-ESO-1 expression 110-300 185-300 Transduced T cells ... stable disease; TTR, time to response. Post ...
Efficacy endpoints include ORR, DoR, TTR, PFS and OS. Pharmacokinetic ... Translational Lung Cancer Research. 2015;4(2), 110-118. 6 American Cancer Society. Targeted Drug Therapy for Non-Small ...
Per SD increase of TTR was associated with significantly decreased risks of all-cause mortality (110–130 mm Hg SBP TTR: hazard ratios, 0.85 [95% CI, 0.82–0.89]; 120–140 mm Hg SBP TTR: 0.81 [95% CI, ...
Efficacy endpoints include ORR, DoR, TTR, PFS and OS. Pharmacokinetic ... Translational Lung Cancer Research. 2015;4(2), 110-118. 6 American Cancer Society. Targeted Drug Therapy for Non-Small Cell ...
Efficacy endpoints include ORR, DoR, TTR, PFS and OS. Pharmacokinetic ... Translational Lung Cancer Research. 2015; 4(2), 110-118. 7. American Cancer Society. Targeted Drug Therapy for Non-Small Cell ...
won GT4 and the title after fuel pressure problems for the No.496 Continental TTR Racing Toyota GR Supra GT4 EVO. In TCE-TCX, CHAZEL Technologie Course won with the No.110 Alpine A110 of Felix Crepet, ...
Only show cars that can be delivered to me. Please enter your postal code in order to show cars that can be delivered to you.
[Stay on top of transportation news: Get TTNews in your inbox.] The transportation sector saw merger and acquisition activity gain momentum as market conditions stabilized in the second half of ...
On November 22, 2024, the U.S. Food and Drug Administration (FDA) approved Attruby (acoramidis), a near-complete TTR stabilizer (≥90%), to reduce cardiovascular death and cardiovascular-related ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results